Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. (Q38289104)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Marta López-Parra

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Raquel Horrillo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Ana González-Périz

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Marcos Martínez-Clemente

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Anna Planagumà

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Jaime Masferrer

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

21 July 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Journal of Lipid Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

49

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2513-2523

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Animal models of steatohepatitis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Insulin and glucose play a role in foam cell formation and function

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Localization of microsomal triglyceride transfer protein in the Golgi: possible role in the assembly of chylomicrons

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Prostaglandins and leukotrienes: advances in eicosanoid biology

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Eicosanoids, signal molecules of liver cells

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Leukotriene uptake by hepatocytes and hepatoma cells

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4).

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M800101-JLR200

21 January 2018

Identifiers

10.1194/JLR.M800101-JLR200

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645210%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38289104&oldid=1509855457"